• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Start-Up Stadium Thursday

Thursday, June 06, 2024
5B
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event. During the 2024 BIO International Convention select finalists from around the world will share a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor judges, followed by live feedback. This year will also feature evaluation of the presentations from seed-stage company finalists (less than $1M raised) separate from emerging company finalists (more than $1M but less than $10M raised to date). with a winner identified for each category. Past prizes have included 'fast-track' admission review to incubator programs at the Illumina Accelerator and The Innovation Space, as well as complimentary, one-year memberships in the Biotechnology Innovation Organization with access to the cost-savings programs of BIO Business Solutions.
Loading
11:00 AM – 1:00 PM
(PST)
  1. We are pioneering a novel approach by integrating proprietary synthetic biology methods and de novo protein designs with the power of generative AI to automate the discovery process and develop patient-tailored immune-mediated therapies at scale for Chronic and Age-Related diseases.
    Start-Up Stadium Session
    • Platform for Therapeutics
  2. Endure Biotherapeutics (“Endure Bio”®) is developing engineered engraftable live biotherapeutics for metabolic diseases by genetically engineering human native bacteria to express therapeutic compounds.
    Start-Up Stadium Session
    • Platform for Therapeutics
  3. HBI is a private company focused on developing cutting-edge Microbiome-Based Therapeutics.
    Start-Up Stadium Session
    • Platform for Therapeutics
  4. Leverna Therapeutics is a Boston-based preclinical RNA therapeutics company developing a portfolio of CNS-focused antisense oligonucleotide (ASO) programs.
    Start-Up Stadium Session
    • CNS/Neurological
  5. Neuronascent Inc. discovers and develops novel neuron regenerative therapies for neurodegenerative and rare pediatric neurological diseases.
    Start-Up Stadium Session
    • CNS/Neurological
  6. Origami Therapeutics is developing curative therapies that target and degrade disease-related proteins.
    Start-Up Stadium Session
    • CNS/Neurological
  7. Papillon Therapeutics is a biotechnology company advancing genetic medicines for life threatening conditions with neurologic disease.
    Start-Up Stadium Session
    • CNS/Neurological
  8. Suntec has a proprietary MINC (Multi-target Immune-modulation Nanocomplex) technology platform to develop highly effective and safe immunotherapies.
    Start-Up Stadium Session
    • Platform for Therapeutics
  9. Trust Bio-sonics Inc. is a Taiwan based pharmaceutic company (Private) and a world leader in microsphere technologies for contrast-enhanced ultrasound imaging and ultrasound-mediated drug delivery technologies.
    Start-Up Stadium Session
    • Platform for Therapeutics
  10. Vyro is a worldwide pioneer in the development of therapies and drug-delivery viral vectors based on Zika.
    Start-Up Stadium Session
    • Platform for Therapeutics

 
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS